共 50 条
- [21] Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignanciesInvestigational New Drugs, 2006, 24 : 117 - 123Cheryl D. Cho论文数: 0 引用数: 0 h-index: 0机构: Stanford University School of Medicine,Oncology Division, Department of MedicineGeorge A. Fisher论文数: 0 引用数: 0 h-index: 0机构: Stanford University School of Medicine,Oncology Division, Department of MedicineJoanne Halsey论文数: 0 引用数: 0 h-index: 0机构: Stanford University School of Medicine,Oncology Division, Department of MedicineBranimir I. Sikic论文数: 0 引用数: 0 h-index: 0机构: Stanford University School of Medicine,Oncology Division, Department of Medicine
- [22] Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal CancerAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 56 - 60Chayahara, Naoko论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Div Endocrinol Diabet & Metab, Dept Internal Med, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Div Clin Pharmacokinet, Dept Gen Therapeut, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanTamura, Takao论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Div Endocrinol Diabet & Metab, Dept Internal Med, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanYamamori, Motohiro论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanKadowaki, Yuko论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanOkuno, Tatsuya论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Div Clin Pharmacokinet, Dept Gen Therapeut, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanMiki, Ikuya论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanTsuda, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Hyogo Canc Ctr, Dept Gastroenterol, Akashi, Hyogo, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanNishisaki, Hogara论文数: 0 引用数: 0 h-index: 0机构: Hyogo Canc Ctr, Dept Gastroenterol, Akashi, Hyogo, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanMaeda, Tetsuo论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Hosp, Dept Gastroenterol, Kobe, Hyogo, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanInoue, Yoshifumi论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Hosp, Dept Surg, Kobe, Hyogo, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanOkumura, Katsuhiko论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Div Clin Pharmacokinet, Dept Gen Therapeut, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan论文数: 引用数: h-index:机构:Kasuga, Masato论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Div Endocrinol Diabet & Metab, Dept Internal Med, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanSakaeda, Toshiyuki论文数: 0 引用数: 0 h-index: 0机构: Kyoto Univ, Grad Sch Pharmaceut Sci, Frontier Educ Ctr, Ctr Integrat Educ Pharm Frontier, Kyoto, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, JapanHirai, Midori论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ, Grad Sch Med, Div Clin Pharmacokinet, Dept Gen Therapeut, Kobe, Hyogo 6500017, Japan Kobe Univ, Sch Med, Dept Hosp Pharm, Kobe, Hyogo 6500017, Japan Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan
- [23] An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancerEUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 48 - 55Caponigro, F.论文数: 0 引用数: 0 h-index: 0机构: Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, Italy Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, ItalyLacombe, D.论文数: 0 引用数: 0 h-index: 0机构: EORTC, Brussels, Belgium Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, ItalyTwelves, C.论文数: 0 引用数: 0 h-index: 0机构: St Jamess Inst Oncol, Leeds, W Yorkshire, England Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, ItalyBauer, J.论文数: 0 引用数: 0 h-index: 0机构: CHU Vaudois, CH-1011 Lausanne, Switzerland Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, ItalyGovaerts, A. -S.论文数: 0 引用数: 0 h-index: 0机构: EORTC, Brussels, Belgium Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, ItalyMarreaub, S.论文数: 0 引用数: 0 h-index: 0机构: EORTC, Brussels, Belgium Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, ItalyMilano, A.论文数: 0 引用数: 0 h-index: 0机构: Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, Italy Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, ItalyAnthoney, A.论文数: 0 引用数: 0 h-index: 0机构: St Jamess Inst Oncol, Leeds, W Yorkshire, England Natl Tumour Inst Naples Fde G Pascale, I-80131 Naples, Italy
- [24] A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal CancerCLINICAL CANCER RESEARCH, 2009, 15 (09) : 3189 - 3195Fakih, Marwan G.论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Buffalo, NY 14260 USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USAPendyala, Lakshmi论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USAFetterly, Gerald论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USAToth, Karoli论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USAZwiebel, James A.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst, Canc Therapy Evaluat Program, Bethesda, MD USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USAEspinoza-Delgado, Igor论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Inst, Canc Therapy Evaluat Program, Bethesda, MD USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USALitwin, Alan论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Radiol, Buffalo, NY 14263 USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USARustum, Youcef M.论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USARoss, Mary Ellen论文数: 0 引用数: 0 h-index: 0机构: Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USAHolleran, Julianne L.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Dept Med, Pittsburgh, PA USA Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USAEgorin, Merrill J.论文数: 0 引用数: 0 h-index: 0机构: Univ Pittsburgh, Dept Med, Pittsburgh, PA USA Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
- [25] A phase I/pharmacologic study of UCN-01 in combination with 5-fluorouracil in patients with advanced solid tumors.CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3710S - 3710SShah, MA论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKortmansky, J论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKelsen, DP论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAHseuh, C论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKaubisch, A论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USASpriggs, D论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAGonen, M论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USATong, W论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAEndres, S论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USASchwartz, GK论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
- [26] Phase I trial of BAY 43-9006 in combination with 5-fluorouracil (5-FU) and leucovorin (LCV) in patients with advanced refractory solid tumorsANNALS OF ONCOLOGY, 2004, 15 : 87 - 88Figer, A.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelMoscovici, M.论文数: 0 引用数: 0 h-index: 0机构: Bayer Pharma Clin, Oncol, Nes Zyona, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelBulocinic, S.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelRadu, P.论文数: 0 引用数: 0 h-index: 0机构: Simbec, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelAtsmon, J.论文数: 0 引用数: 0 h-index: 0机构: Simbec, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelShmuely, E.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelLaba, O.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelGadish, D.论文数: 0 引用数: 0 h-index: 0机构: Bayer Pharma Clin, Oncol, Nes Zyona, Israel Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelBrendel, E.论文数: 0 引用数: 0 h-index: 0机构: Bayer HealthCare, Oncol, Elberfeld, Germany Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, IsraelSchwartz, B.论文数: 0 引用数: 0 h-index: 0机构: Bayer Pharmaceut Corp, Oncol, West Haven, CT USA Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Oncol, IL-69978 Tel Aviv, Israel
- [27] Phase 1b dose escalation study of erlotinib in combination with infusional 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced solid tumorsCLINICAL CANCER RESEARCH, 2007, 13 (02) : 523 - 531Hanauske, Axel-R.论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, Germany Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyCassidy, Jim论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanySastre, Javier论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyBolling, Claus论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyJones, Robert J.论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyRakhit, Ashok论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyFettner, Scott论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyBrennscheidt, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyFeyereislova, Andrea论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, GermanyDiaz-Rubio, Eduardo论文数: 0 引用数: 0 h-index: 0机构: Asklepios Hosp St Georg, Dept Med, D-20099 Hamburg, Germany
- [28] Final analysis of MCO27C: a phase I trial of CCI-779 and EKB-569 in patients with advanced solid tumorsCANCER RESEARCH, 2009, 69Bryce, Alan论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USASarkaria, Jann论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAReid, Joel论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USARao, Ravi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAQi, Yingwei论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAQin, Rui论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAJames, C.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAJenkins, Robert论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAErlichman, Charles论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA
- [29] Final analysis of MC027C: a phase I trial of CCI-779 and EKB-569 in patients with advanced solid tumorsCANCER RESEARCH, 2009, 69Bryce, Alan论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USASarkaria, Jann论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAReid, Joel论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USARao, Ravi论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAQi, Yingwei论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAQin, Rui论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAJames, C.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAJenkins, Robert论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USAErlichman, Charles论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Rochester, MN USA
- [30] A Phase Ib Study of the Simmitecan Single Agent and in Combination With 5-Fluorouracil/Leucovorin or Thalidomide in Patients With Advanced Solid TumorFRONTIERS IN PHARMACOLOGY, 2022, 13Zhang, Qi论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaDeng, Ting论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaYang, Fen论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Natl Drug Clin Trial Ctr, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaGuo, Weijian论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaLiu, Dan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaYuan, Jiajia论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaQi, Changsong论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaCao, Yanshuo论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaYu, Qiuqiong论文数: 0 引用数: 0 h-index: 0机构: Haihe Biopharm Co Ltd, Shanghai, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaCai, Huiming论文数: 0 引用数: 0 h-index: 0机构: Haihe Biopharm Co Ltd, Shanghai, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaPeng, Zhi论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaWang, Xicheng论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaZhou, Jun论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaLu, Ming论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaGong, Jifang论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaLi, Jian论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaBa, Yi论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R ChinaShen, Lin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Minist Educ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China